SOUTH AFRICAN DRUG DISCOVERY: GLOBAL HEALTH AND POSTCOLONIAL SCIENCE

Co-presented with the Biopolitics of Science Network 
<http://sydney.edu.au/arts/biopolitics_science/>   and the Race and Ethnicity 
in the Global South <http://sydney.edu.au/arts/regs>  laureate program.

Pharmaceuticals have long traveled the globe, but pharmaceutical 
knowledge-making has been concentrated in just a few places.  Relatedly, Africa 
has long been an obvious place for thinking about global health, but it has 
rarely been considered as a site of global science.  What if Africa were to 
become a place of not just raw materials and end users, but of the science of 
pharmaceutical knowledge-making?

This talk draws on ethnographic research at iThemba Pharmaceuticals, a small 
South African startup pharmaceutical company with an elite international 
scientific board, which was founded with the mission of drug discovery for TB, 
HIV, and malaria. This particular place provides an entry point for exploring 
how the location of the scientific knowledge component of pharmaceuticals - 
rather than their production, licensing, or distribution - matters.  
Consideration of this case illuminates the limitations of global health 
frameworks that implicitly posit the global north as the unique site of 
knowledge production, and thus as the source of unidirectional knowledge flows 
from north to south.  It also provides a concrete example for consideration of 
the contexts and practices of postcolonial science, its constraints and its 
promise.

 Anne Pollock is an Assistant Professor of Science, Technology, and Culture in 
the School of Literature, Media, and Communication at Georgia Tech. Pollock's 
research focuses on biomedicine and culture. She is particularly interested in 
how medical categories and technologies are enrolled in telling stories about 
identity and difference, especially with regard to race, gender, and 
citizenship. Her new book, Medicating Race: Heart Disease and Durable 
Preoccupations with Difference, tracks the intersecting discourses of race, 
pharmaceuticals, and cardiovascular disease in the United States from the 
founding of cardiology to the controversial approval of BiDil for heart failure 
in "self-identified black patients." She is also engaged in ongoing projects in 
three areas: feminism and heart disease; American health disparities and 
citizenship claims; and drug discovery efforts by and for the Global South 
(specifically South Africa).

THURSDAY 8 AUGUST, 2013
6.30 - 8.00pm
Law School LT 024
 New Law School, Eastern Avenue,
 The University of Sydney
 Click here <http://sydney.edu.au/law/about/campus.shtml>  for venue information


RSVP
Free event with registration requested. Click here 
<http://whatson.sydney.edu.au/events/planning/assistant-professor-anne-pollock> 
 to register online now.

 Stay connected with Sydney Ideas and like us on facebook 
<http://www.facebook.com/sydney.ideas>  and follow us on twitter. 
<https://twitter.com/Sydney_Ideas>  You'll be the first to hear about upcoming 
events and special offers.




To make sure you continue to see our emails in the future, please add 
[email protected] <mailto:[email protected]> to your address 
book or safe senders list

If you do you not wish to receive any further emails from Sydney Ideas, please 
reply to this email with UNSUBSCRIBE in the subject line.

Disclaimer <http://sydney.edu.au/disclaimer.shtml> | Privacy statement 
<http://sydney.edu.au/privacy.shtml> | University of Sydney 
<http://sydney.edu.au/>







------ End of Forwarded Message
_______________________________________________
SydPhil mailing list: http://bit.ly/sydphil

New archive: http://bit.ly/SydPhilArchive

To UNSUBSCRIBE, change your MEMBERSHIP OPTIONS, find ANSWERS TO COMMON 
PROBLEMS, or visit our ONLINE ARCHIVES, please go to the LIST INFORMATION PAGE: 
http://bit.ly/sydphil ... and if you can't get to that page, try the EMERGENCY 
PAGE: http://bit.ly/SydPhilEmergency

Reply via email to